Veterans' Affairs Pharmaceutical Benefits Schemes Amendment Determination 2021 (Cth)

Veterans’ Affairs Pharmaceutical Benefits Schemes Amendment Determination 2021

Instrument 2020 No. R43/MRCC43

I, Natasha Cole, as delegate of the Minister for Veterans’ Affairs, approve:

(a) for the purposes of subsection 286(6) of the Military Rehabilitation and Compensation Act 2004—the amendments by the Military Rehabilitation and Compensation Commission of the MRCA Pharmaceutical Benefits Scheme in the following determination; and

(b) for the purposes of subsection 91(5) of the Veterans’ Entitlements Act 1986—the amendments by the Repatriation Commission of the Repatriation Pharmaceutical Benefits Scheme in the following determination.

Dated       18th              day  of             February   2021

...Natasha Cole...

Natasha Cole

Acting Deputy Secretary, Veterans and Families Services

Department of Veterans’ Affairs

The Military Rehabilitation and Compensation Commission, under subsection 286(5) of the Military Rehabilitation and Compensation Act 2004, make the amendments of the MRCA Pharmaceutical Benefits Scheme in the following determination.

Dated   18th          day    of       February            2021

The Seal of the   )

Military Rehabilitation and Compensation Commission          )

was affixed to this determination   )

in the presence of:   )

…………Elizabeth Cosson……………….	………………Kate Pope…………………	…Donald Spinks…..
ELIZABETH COSSON AM CSC	KATE POPE PSM	DONALD SPINKS AM
Chair	Member	Member
………….…Sarah Sharkey……………	…………….Natasha Fox………….
REAR ADMIRAL SARAH SHARKEY	MAJOR GENERAL NATASHA FOX
AM CSC RAN	AM CSC
Member	Member

The Repatriation Commission, under subsection 91(4) of the Veterans’ Entitlements Act 1986, makes the amendments of the Repatriation Pharmaceutical Benefits Scheme in the following determination.

Dated      18th   day      of         February            2021

The Seal of the      )

Repatriation Commission   )

was affixed to this determination   )

in the presence of:   )

…… Elizabeth Cosson ……..	…………… Kate Pope ………….	…..… Donald Spinks ….
ELIZABETH COSSON AM CSC	KATE POPE PSM	DONALD SPINKS AM
President	Deputy President	Commissioner
……Gwen Cherne……	……Stuart Smith….
GWEN CHERNE	STUART SMITH
AO DSC
Commissioner	Commissioner

Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule—Amendments   2

MRCA Pharmaceutical Benefits Scheme   2

Repatriation Pharmaceutical Benefits Scheme   2

1  Name

This instrument is the Veterans’ Affairs Pharmaceutical Benefits Schemes Amendment Determination 2021.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	The day after it is registered.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under the following:

(a) section 286 of the Military Rehabilitation and Compensation Act 2004;

(b) section 91 of the Veterans’ Entitlements Act 1986.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule—Amendments

MRCA Pharmaceutical Benefits Scheme

1  Paragraph 40A(1)(c)

Omit “section 98C” (both occurring) and substitute “section 98AC”.

Repatriation Pharmaceutical Benefits Scheme

2  Paragraph 40A(1)(c)

Omit “section 98C” (both occurring) and substitute “section 98AC”.